159 related articles for article (PubMed ID: 36922784)
21. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
22. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline.
Venturella R; Lukes AS; Wu R; McLean R; Rakov VG; Al-Hendy A
Int J Gynaecol Obstet; 2024 May; 165(2):431-441. PubMed ID: 38576220
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Ali M; Chen HY; Chiang YF; Badary OA; Hsia SM; Al-Hendy A
Expert Opin Pharmacother; 2022 Mar; 23(4):421-429. PubMed ID: 35068291
[TBL] [Abstract][Full Text] [Related]
24. Morphologic assessment of endometrium overlying submucosal leiomyomas.
Patterson-Keels LM; Selvaggi SM; Haefner HK; Randolph JF
J Reprod Med; 1994 Aug; 39(8):579-84. PubMed ID: 7996520
[TBL] [Abstract][Full Text] [Related]
25. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials: Correction.
Obstet Gynecol; 2022 Jul; 140(1):138. PubMed ID: 35849476
[No Abstract] [Full Text] [Related]
26. Hysteroscopic enucleation of type II submucosal uterine leiomyomas using a TRUCLEAR hysteroscopic morcellator: case report and review of the literature.
Pakrashi T; Ressler IB; Sroga JM; DiPaola KB; Thomas MA; Lindheim SR
J Laparoendosc Adv Surg Tech A; 2013 Apr; 23(4):378-82. PubMed ID: 23477370
[TBL] [Abstract][Full Text] [Related]
27. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
28. Pathological characteristics and clinical outcome of uterine leiomyomas associated with pregnancy.
Muezzinoglu B; Corakci A
Pathol Res Pract; 2011 Nov; 207(11):691-4. PubMed ID: 21993296
[TBL] [Abstract][Full Text] [Related]
29. Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.
Osuga Y; Seki Y; Tanimoto M; Kusumoto T; Kudou K; Terakawa N
BMC Womens Health; 2021 Jun; 21(1):250. PubMed ID: 34154590
[TBL] [Abstract][Full Text] [Related]
30. Hemorrhagic cellular leiomyomas ("apoplectic leiomyoma") of the uterus associated with pregnancy and oral contraceptives.
Norris HJ; Hilliard GD; Irey NS
Int J Gynecol Pathol; 1988; 7(3):212-24. PubMed ID: 3182168
[TBL] [Abstract][Full Text] [Related]
31. Prolapse of a pedunculated uterine leiomyoma through the cervix during GnRH antagonist treatment: Case report and literature review.
Ishizawa C; Hirota Y; Urata Y; Morishima K; Fujii T; Osuga Y
J Obstet Gynaecol Res; 2020 Sep; ():. PubMed ID: 32911575
[TBL] [Abstract][Full Text] [Related]
32. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization.
Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
[No Abstract] [Full Text] [Related]
33. Primary postpartum haemorrhage due to a large submucosal nonpedunculated uterine leiomyoma: a case report and review of the literature.
Akrivis Ch; Varras M; Bellou A; Kitsiou E; Stefanaki S; Antoniou N
Clin Exp Obstet Gynecol; 2003; 30(2-3):156-8. PubMed ID: 12854866
[TBL] [Abstract][Full Text] [Related]
34. Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient.
Prescrire Int; 2014 May; 23(149):130-5. PubMed ID: 24926520
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis.
Bittencourt CA; Dos Santos Simões R; Bernardo WM; Fuchs LFP; Soares Júnior JM; Pastore AR; Baracat EC
Ultrasound Obstet Gynecol; 2017 Jul; 50(1):32-39. PubMed ID: 27862503
[TBL] [Abstract][Full Text] [Related]
36. Relugolix: First Global Approval.
Markham A
Drugs; 2019 Apr; 79(6):675-679. PubMed ID: 30937733
[TBL] [Abstract][Full Text] [Related]
37. Uterine artery ligation for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section.
Liu WM; Wang PH; Tang WL; Wang IT; Tzeng CR
Fertil Steril; 2006 Aug; 86(2):423-8. PubMed ID: 16762346
[TBL] [Abstract][Full Text] [Related]
38. Ileal hemorrhage caused by a parasitic uterine leiomyoma.
Rader JS; Binette SP; Brandt TD; Sreekanth S; Chhablani A
Obstet Gynecol; 1990 Sep; 76(3 Pt 2):531-4. PubMed ID: 2381642
[TBL] [Abstract][Full Text] [Related]
39. Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patients.
Rothmund R; Kurth RR; Lukasinski NM; Huebner M; Hartkopf A; Wallwiener M; Staebler A; Brucker SY; Taran FA
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):358-61. PubMed ID: 24176540
[TBL] [Abstract][Full Text] [Related]
40. Severe intrauterine growth restriction associated with the development of a submucosal leiomyoma during pregnancy: a case report.
Aziz N; Lenzi TA; Milki AA
J Reprod Med; 2005 Jul; 50(7):553-6. PubMed ID: 16130857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
